Government advisers are meeting Thursday to decide if COVID-19 vaccines need updating to improve protection this fall and ...

FDA COVID vaccine update is stirring major public attention as a new policy limits fall COVID-19 booster shots to seniors and ...

The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials ...

The approval of Nuvaxovid for use in older and high-risk adults will generate around $175 million in milestone payments from ...

The FDA also requested Novavax conduct a phase 4 study in patients aged 50 to 64 years without high-risk conditions for severe COVID-19.

Blood and urine tests might be able to reveal how much of your diet is made up of industrially produced foods, a new study ...

The Trump administration said Tuesday it will limit approval for seasonal COVID-19 shots to seniors and others at high risk pending more data on everyone else — raising questions about whether some ...

The FDA has granted full approval for Novavax's COVID-19 vaccine, but with restrictions. Discover the details now.

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...